At some point during their grade school years, lots of kids go through a big mythology phase -- they can't get enough of stories about gods, goddesses, and other mythological creatures. And that love ...

The Olympic Opening Ceremony's controversy has renewed interest in divine dinners, during which sitting down for food is more than a meal.

In Greek mythology, Hera was the goddess of women, marriage and married life. She was the queen of the gods by her marriage ...

Other divinities in Greek mythology ... Thetis at Kylix by the Foundry Painter Antikensammlung Berlin. Credit: Public domain. Then there was Hephaistos, the Leonardo da Vinci of his time. He was a ...

The best Olympus lenses – and the best OM System lenses, as that's what the brand is now called – comprise some of the greatest glass I've ever used, on any camera system. While the Micro Four Thirds ...

ESSEX, CT, USA I February 19, 2025 I Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to ...

The best Olympus cameras – and the best OM System cameras, as the brand is now known – are truly unique in the world of mirrorless cameras for three reasons. Their biggest trump card, however, is that ...

ESSEX, Conn.--(BUSINESS WIRE)--Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to ...

ESSEX, Conn., February 19, 2025--(BUSINESS WIRE)--Thetis Pharmaceuticals LLC ("Thetis"), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the ...

Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel ...

ESSEX, Conn., February 19, 2025--(BUSINESS WIRE)--Thetis Pharmaceuticals LLC ("Thetis"), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 ...

ESSEX, Conn.--(BUSINESS WIRE)--#IBD--Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to ...